Cancer Immunology, Immunotherapy

, Volume 33, Issue 6, pp 395–397 | Cite as

Interleukin-6 does not support interleukin-2 induced generation of human lymphokine-activated killer cells

  • Hans-G. Klingemann
  • Elaine Wong
Original articles

Summary

The activity of lymphokine-activated killer (LAK) cells is supported by various cytokines. The objective of this study was to see if recombinant interleukin-6 (IL-6) either alone or in combination with interleukin-2 (IL-2) has any effect on the generation of LAK cells. Peripheral blood mononuclear cells of healthy donors were cultured for 4 or 6 days with both cytokines either alone or in combination. LAK activity against K562 and natural killer-resistant Daudi cells was assessed by a 4-h and an 18-h51Cr-release assay at various effector to target ratios. IL-6 alone in increasing concentrations did not induce LAK cell activity. Neither additive nor synergistic effects of IL-6 with IL-2 were observed. Immunofluorescence analysis with phycoerythrin-conjugated anti-CD56 antibody demonstrated that IL-6 could not maintain or increase the number of CD56-positive cells over a 6-day culture period. These results suggest that IL-6 does not support LAK cell generation by itself or increase LAK cell activity in combination with IL-2.

Key words

Interleukin-6 LAK cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aarden LA, De Groot ER, Shaap OL, Landsdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411Google Scholar
  2. 2.
    Aoki T, Kikuchi H, Miyatake S-I, Oda Y, Iwasaki K, Yamasaki T, Kinashi T, Honjo T (1989) Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity. J Exp Med 170: 583Google Scholar
  3. 3.
    Alderson MR, Sassenfeld HM, Widmer MB (1990) Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J Exp Med 172: 577Google Scholar
  4. 4.
    Brook B, Rees RC (1988) Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity. Clin Exp Immunol 74: 162Google Scholar
  5. 5.
    Ellis TM, McKenzie RS, Simms PE? Helfrich BA, Fisher RI (1989) Induction of human lymphokine-activated killer cells by IFN-α and IFN-γ. J Immunol 143: 4282Google Scholar
  6. 6.
    Gallagher G, Stimson WH, Findlay J, Al-Azzawi F (1990) Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother 31: 49Google Scholar
  7. 7.
    Grimm EA, Mazumder A, Zhang HZ (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2 activated autologous peripheral blood lymphocytes. J Exp Med 155: 1823Google Scholar
  8. 8.
    Hack CE, De Groot ER, Richelle JF, Nuijens JH, Strack Van Schijndel R, Erenberg-Belmer AJM, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704Google Scholar
  9. 9.
    Itoh K, Pellis NR, Balch CM (1989) Monocyte dependent serumborne suppressor of lymphokine-activated killer cell induction of lymphocytes from melanoma patients. Cancer Immunol Immunother 29: 57Google Scholar
  10. 10.
    Nagler A, Lanier LL, Phillips JH (1988) The effects of IL-4 on human natural killer cells. J Immunol 141: 2349Google Scholar
  11. 11.
    Parmiani G (1990) An explanation of the variable clinical responses to interleukin-2 and LAK cells. Immunol Today 11: 113Google Scholar
  12. 12.
    Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485Google Scholar
  13. 13.
    Stulting RD, Berke G (1973) The use of51Cr release as a measure of lymphocyte-mediated cytolysis in vitro. Cell Immunol 9: 474Google Scholar
  14. 14.
    van der Schoot CE, Jansen P, Poorter M, Wester MR, von dem Borne AEK, Aarden LA, van Oers RHJ (1989) Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 74: 2081Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Hans-G. Klingemann
    • 1
  • Elaine Wong
    • 1
  1. 1.Terry Fox Laboratory, British Columbia Cancer Agency, Division of HematologyUniversity of British ColumbiaVancouverCanada

Personalised recommendations